As of 17 Sept 2026, Dr Reddys Laboratories Ltd share price is ₹1,153.80. The stock opened at ₹1,153.80 and had closed at ₹1,145.25 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,080.05 and a high of ₹1,414.40. In terms of performance, Dr Reddys Laboratories Ltd share price has decreased by 11.51% over the past six months and has decreased by 13.40% over the last year.
DRREDDY Stock Price Chart
Dr Reddys Laboratories Ltd Overview
About DRREDDY
Dr Reddys Laboratories a prominent global pharmaceutical company headquartered in Hyderabad, India. Founded in 1984, it is a leader in affordable medicines, offering a wide array of active pharmaceutical ingredients (APIs), generics, branded generics, and biosimilars across key therapeutic areas like oncology, cardiovascular care, and diabetology.
Dr Reddys Laboratories Ltd Historical Performance
DRREDDY Futures & Options
Dr Reddys Laboratories Ltd Fundamentals
Dr Reddys Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 22,222.40 | 24,118.80 | 20,346.10 | 17,553.80 | 14,887.20 |
| EBITDA | 5,607.00 | 8,385.20 | 6,788.70 | 4,806.10 | 3,076.10 |
| Net Profit | 3,219.70 | 5,349.40 | 4,342.00 | 2,612.80 | 1,623.20 |
| EPS | 38.68 | 64.22 | 260.95 | 157.37 | 97.85 |
Dr Reddys Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,136.18 |
| Resistance 1 (R1) | 1,152.13 |
| Pivot Point | 1,143.07 |
Dr Reddys Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 10-Jul-2026 | 12-May-2026 | 10-Jul-2026 | Final | ₹8.00 |
| 10-Jul-2025 | 09-May-2025 | 10-Jul-2025 | Final | ₹8.00 |
| 16-Jul-2024 | 07-May-2024 | 17-Jul-2024 | Final | ₹40.00 |
| 11-Jul-2023 | 10-May-2023 | 12-Jul-2023 | Final | ₹40.00 |
| 11-Jul-2022 | 19-May-2022 | 13-Jul-2022 | Final | ₹30.00 |
DRREDDY Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Satish Reddy | Chairman |
| G V Prasad | Managing Director |
| Leo Puri | Non Executive Independent Director |
Dr Reddys Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,861.70+0.44% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,287.00+1.41% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,818.00+0.11% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Dr Reddys Laboratories Ltd today is ₹1,153.80 on NSE and ₹1,153.80 on BSE.
- The 52-week high of Dr Reddys Laboratories Ltd is ₹1,414.40, while the 52-week low is ₹1,080.05.
- The current market capitalisation of Dr Reddys Laboratories Ltd is approximately ₹95,592 crore.
- The P/E (Price-to-Earnings) ratio of Dr Reddys Laboratories Ltd is 19.51. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Dr Reddys Laboratories Ltd is 2.99. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Dr Reddys Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for DRREDDY on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Dr Reddys Laboratories Ltd has delivered a return of approximately -1.65%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Dr Reddys Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 26.64% promoters, 18.92% FIIs, 31.74% DIIs, and 7.42% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
